Free Trial
→ Important: case study on TGT (From Wealthpin Pro) (Ad) Free ASND Stock Alerts

Ascendis Pharma A/S (ASND) SEC Filings & 10K Form

Ascendis Pharma A/S logo
$152.43 -2.15 (-1.39%)
Closing price 04:00 PM Eastern
Extended Trading
$152.51 +0.08 (+0.05%)
As of 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Ascendis Pharma A/S SEC Filings

Export to Excel
DateFilerForm TypeView
02/19/2025
4:06 PM		Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
3:56 PM		Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
10:54 AM		Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/12/2025
3:15 PM		Ascendis Pharma A/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/12/2025
2:24 PM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/11/2025
8:15 AM		Ascendis Pharma A/S (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
Form SCHEDULE 13G/A
01/15/2025
3:39 PM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/13/2025
5:03 AM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/13/2025
5:05 AM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
3:04 PM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
5:04 AM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2024
4:02 PM		Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
4:07 PM		Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
4:16 PM		Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:44 PM		Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
3:35 PM		Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:46 PM		Ascendis Pharma A/S (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
1:57 PM		Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
11/14/2024
8:31 AM		Ascendis Pharma A/S (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G/A
11/13/2024
3:02 PM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2024
8:51 AM		Artisan Partners Limited Partnership (Filed by)
Ascendis Pharma A/S (Subject)
Form SC 13G/A
11/08/2024
9:34 AM		Ascendis Pharma A/S (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/04/2024
6:05 AM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
7:35 AM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:59 PM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
4:20 PM		Ascendis Pharma A/S (Filer)
Form 424B5
09/18/2024
3:01 PM		Ascendis Pharma A/S (Filer)
Form F-3ASR
09/16/2024
6:28 AM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
6:32 AM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2024
3:01 PM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
4:10 PM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
4:11 PM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
4:14 PM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/12/2024
6:05 AM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2024
5:07 AM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2024
3:26 PM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
3:08 PM		Ascendis Pharma A/S (Filer)
Form SD
Specialized Disclosure Report  
05/14/2024
1:37 PM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
8:16 AM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
10:31 AM		Ascendis Pharma A/S (Subject)
Bodenhoff Mads (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
8:39 PM		Ascendis Pharma A/S (Subject)
Fairey William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Critical ‘Buy Now’ Alert on My Favorite Stock! (Ad)

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>
03/05/2024
8:47 AM		Ascendis Pharma A/S (Subject)
Cha Albert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
7:04 AM		Ascendis Pharma A/S (Subject)
SPROGOE KENNETT (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
7:14 AM		Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:52 AM		Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:37 AM		Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
1:54 PM		Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
2:07 PM		Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
2:17 PM		Ascendis Pharma A/S (Subject)
RASMUSSEN PETER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
1:36 PM		Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
1:24 PM		Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
10:00 AM		Ascendis Pharma A/S (Subject)
HOLTUG LARS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:13 PM		Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:21 PM		Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2024
5:17 PM		Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
4:45 PM		Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
2:17 PM		Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ASND) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Elon “obliterates” Bill Gates?
All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...
Altimetry | Sponsored
NVDA Crash Update
An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...
Chaikin Analytics | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
My 2025 AI Blueprint
I first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...
Weiss Ratings | Sponsored
Better than Bitcoin – and potentially more profitable
The world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...
Brownstone Research | Sponsored